Brief: Vallon Pharmaceuticals Inc Increased Size Of Board From Five Directors To Six Directors
28/02/2022 21:30
Feb 28 (Reuters) - Vallon Pharmaceuticals Inc VLON.O :
* VALLON PHARMACEUTICALS INC - ON FEBRUARY 23, BOARD
INCREASED
SIZE OF BOARD FROM FIVE DIRECTORS TO SIX DIRECTORS
Further company coverage: VLON.O
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027